Bridgepoint Group (LON:BPT) Reaches New 1-Year High – Should You Buy?

Bridgepoint Group plc (LON:BPT – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as GBX 415.80 and last traded at GBX 412, with a volume of 1,328,135 shares. The stock had previously closed at GBX 401.80.

Analyst Ratings Changes

Several brokerages recently issued reports on BPT. Berenberg Bank restated a “buy” rating and issued a GBX 360 price objective on shares of Bridgepoint Group in a report on Friday, September 18th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 485 target price on shares of Bridgepoint Group in a research report on Thursday, October 8th. Four investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat.com, Bridgepoint Group currently has an average rating of “Buy” and an average price target of GBX 413.75.

Check Out Our Latest Analysis on BPT

Bridgepoint Group Stock Performance

The firm’s fifty day moving average price is GBX 326.47 and its 200 day moving average price is GBX 289.16. The company has a current ratio of 16.31, a quick ratio of 3.60 and a debt-to-equity ratio of 53.71. The stock has a market capitalization of £3.56 billion, a price-to-earnings ratio of 131.53, a price-to-earnings-growth ratio of 0.61 and a beta of 1.39.

Bridgepoint Group Company Profile

(Get Free Report)

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

Further Reading

Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.